Prevalence, Pathogenesis and Management of Anemia in Inflammatory Bowel Disease: An IG-IBD Multicenter, Prospective, and Observational Study
Inflammatory Bowel Diseases · 05.01.2023 · 29 (1) · 76-84
DOI: 10.1093/ibd/izac054 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 02.04.2022. Verfasst von Gaetano Bergamaschi und 44 weiteren Autor:innen. Beteiligte Einrichtung: Medicina Generale I, Fondazione stituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo e Università di Pavia, Pavia, Italy. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Anemia, Iron Deficiencies, Avitaminosis. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Italian Group for Inflammatory Bowel Diseases, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, University of Pavia.
Abstract (Originalsprache)
Background
Anemia is a common extraintestinal manifestation of inflammatory bowel disease (IBD), with a 6% to 74% prevalence and a negative impact on patient survival and quality of life, although the prevalence is apparently declining due to improved disease treatment. We aimed to investigate the prevalence, pathogenesis, and clinical correlates of anemia in Italian patients with IBD.
Methods
A multicenter, prospective, observational study, involving 28 Italian gastroenterology centers, was conducted to investigate the epidemiology and consequences of IBD-associated anemia. Clinical and laboratory data of anemic patients were obtained at study enrolment.
Results
Anemia was diagnosed in 737 of 5416 adult IBD outpatients (prevalence 13.6%); females were more commonly affected than males (odds ratio, 1.5; 95% confidence interval [CI], 1.2–1.7) and had more severe anemia. In the majority of cases, anemia was due to iron deficiency (62.5% of cases; 95% CI, 58.3%–66.6%), either isolated or in association with inflammation and/or vitamin deficiencies; anemia of inflammation accounted for only 8.3% of cases. More severe anemia was associated with increasing fatigue and worse quality of life. Only 68.9% of anemic patients with iron deficiency (95% CI, 63.4%–73.8%) and 34.6% of those with vitamin deficiencies (95% CI, 26.2%–44.2%) were properly treated with supplementation therapy.
Conclusions
In Italy, the prevalence of IBD-associated anemia is lower than previously reported. Anemia of IBD is most commonly due to iron deficiency and contributes to fatigue and poor quality of life, but remains untreated in a large proportion of patients with iron and/or vitamin deficiencies. This study is registered at clinicaltrials.gov as NCT02872376.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medicina Generale I, Fondazione stituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo e Università di Pavia, Pavia, Italy.
- Gastroenterology, Department of Clinical Medicine and Surgery, University Federico II of Naples, Naples, Italy.
- Inflammatory Bowel Disease Unit-Azienda Ospedaliera-University of Padua, Padua, Italy.
- Gastroenterology and Digestive Endoscopy Unit, "Città della Salute e della Scienza" Hospital, Torino, Italy.
- Gastroenterology and Clinical Unit for Inflammatory Bowel Diseases, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
- Unità Operativa Complessa di Gastroenterologia Cinica, Azienda Ospedaliero Universitaria Careggi, Firenze, Italy.
ORCID-Profile: Simone Saibeni, Gionata Fiorino, Maurizio Vecchi, Antonio Di Sabatino
Förderung
- Italian Group for Inflammatory Bowel Diseases
- Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia
- University of Pavia
Zitieren
APA
Bergamaschi, G., Castiglione, F., D'Incà, R., Astegiano, M., Fries, W., Milla, M., Ciacci, C., Rizzello, F., Saibeni, S., Ciccocioppo, R., Orlando, A., Bossa, F., Principi, M., Vernia, P., Ricci, C., Scribano, M. L., Bodini, G., Mazzucco, D., Bassotti, G., …, & Di Sabatino, A. (2023). Prevalence, Pathogenesis and Management of Anemia in Inflammatory Bowel Disease: An IG-IBD Multicenter, Prospective, and Observational Study. Inflammatory Bowel Diseases, 29(1), 76-84. https://doi.org/10.1093/ibd/izac054
Vancouver
Bergamaschi G, Castiglione F, D'Incà R, Astegiano M, Fries W, Milla M, et al. Prevalence, Pathogenesis and Management of Anemia in Inflammatory Bowel Disease: An IG-IBD Multicenter, Prospective, and Observational Study. Inflammatory Bowel Diseases. 2023;29(1):76-84. doi:10.1093/ibd/izac054
BibTeX
@article{Bergamaschi2023,
author = {Bergamaschi, Gaetano and Castiglione, Fabiana and D'Incà, Renata and Astegiano, Marco and Fries, Walter and Milla, Monica and Ciacci, Carolina and Rizzello, Fernando and Saibeni, Simone and Ciccocioppo, Rachele and Orlando, Ambrogio and Bossa, Fabrizio and Principi, Mariabeatrice and Vernia, Piero and Ricci, Chiara and Scribano, Maria L and Bodini, Giorgia and Mazzucco, Dario and Bassotti, Gabrio and Riegler, Gabriele and Buda, Andrea and Neri, Matteo and Caprioli, Flavio and Monica, Fabio and Manca, Aldo and Villa, Erica and Fiorino, Gionata and Comberlato, Michele and Aronico, Nicola and Della Corte, Cristina and Caccaro, Roberta and Gionchetti, Paolo and Giuffrida, Paolo and Iovino, Paola and Lenti, Marco V and Mengoli, Caterina and Pellegrini, Lucienne and Pieraccini, Alberto and Ribaldone, Davide and Testa, Anna and Ubezio, Cristina and Viola, Anna and Vecchi, Maurizio and Klersy, Catherine and Di Sabatino, Antonio},
title = {Prevalence, Pathogenesis and Management of Anemia in Inflammatory Bowel Disease: An IG-IBD Multicenter, Prospective, and Observational Study},
journal = {Inflammatory Bowel Diseases},
year = {2023},
volume = {29},
number = {1},
pages = {76--84},
doi = {10.1093/ibd/izac054}
}
EUVIMED